GC62291
Orantinib
Also listed as (Z)-Orantinib
(Z)-Orantinib ((Z)-SU6668) is a potent, selective, orally active and ATP competitive inhibitor of Flk‐1/KDR, PDGFRβ, and FGFR1, with IC50s of 2·1, 0·008, and 1·2 ?M, respectively· (Z)-Orantinib is a potent antiangiogenic and antitumor agent that induces regression of established tumors
ChemicalCAS210644-62-5MW310.35FormulaC18H18N2O3
- CAS number
- 210644-62-5
- Molecular weight
- 310.35
- Formula
- C18H18N2O3
- Solubility
- DMSO ： 50 mg/mL (161·11 mM; Need ultrasonic)
- InChIKey
- NHFDRBXTEDBWCZ-ZROIWOOFSA-N
- Catalogue number
- GC62291
- Brand
- GLPBIO
Computed properties PubChem CID 5329099 · XLogP 2.2 · TPSA 82.2 Ų · H-bond donors 3
- XLogP
- 2.2
- TPSA
- 82.2 Ų
- H-bond donors
- 3
- H-bond acceptors
- 3
- Rotatable bonds
- 4
- Heavy atoms
- 23
SMILES CC1=C(NC(=C1CCC(=O)O)C)/C=C\2/C3=CC=CC=C3NC2=O
Computed descriptors from PubChem (CID 5329099), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il